Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Takeuchi

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
The Cochrane Database of Systematic Reviews|October 3, 2022
Pharmacological interventions for prevention of weight gain in people with schizophreniaSri Mahavir Agarwal, Nicolette Stogios, Zohra A Ahsan, et al.
The Journal of Clinical Psychiatry|January 12, 2021
Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness DurationSeoyoung Kim, SuYoun Kim, MinJung Koh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2023
Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brainYasuharu Yamamoto, Keisuke Takahata, Manabu Kubota, et al.
BMC Oral Health|August 21, 2012
Dental conditions in inpatients with schizophrenia: a large-scale multi-site surveyHideaki Tani, Hiroyuki Uchida, Takefumi Suzuki, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 7, 2023
Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophreniaSherry Kit Wa Chan, Yi Nam Suen, Wai Ching Yan, et al.
Psychological Medicine|May 28, 2026
Factors associated with social functioning by relapse frequency in Japanese outpatients with schizophrenia: the Multicenter Treatment Survey and Assessments for Schizophrenia in Psychiatric Clinics (MUSASI)Yoshiteru Takekita, Eiichi Katsumoto, Naoto Adachi, et al.
Cell Reports. Medicine|September 29, 2023
Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesiaYoshifumi Abe, Sho Yagishita, Hiromi Sano, et al.
BMC Psychiatry|November 19, 2013
Melancholic and reactive depression: a reappraisal of old categoriesJin Mizushima, Hitoshi Sakurai, Yuya Mizuno, et al.
Schizophrenia Research|June 2, 2023
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definitionGeorgios Schoretsanitis, A Elif Anıl Yağcıoğlu, Can-Jun Ruan, et al.
Schizophrenia Research|July 24, 2023
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studiesCan-Jun Ruan, Ismael Olmos, Carina Ricciardi, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
The Cochrane Database of Systematic Reviews|October 3, 2022
Pharmacological interventions for prevention of weight gain in people with schizophreniaSri Mahavir Agarwal, Nicolette Stogios, Zohra A Ahsan, et al.
The Journal of Clinical Psychiatry|January 12, 2021
Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness DurationSeoyoung Kim, SuYoun Kim, MinJung Koh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2023
Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brainYasuharu Yamamoto, Keisuke Takahata, Manabu Kubota, et al.
BMC Oral Health|August 21, 2012
Dental conditions in inpatients with schizophrenia: a large-scale multi-site surveyHideaki Tani, Hiroyuki Uchida, Takefumi Suzuki, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 7, 2023
Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophreniaSherry Kit Wa Chan, Yi Nam Suen, Wai Ching Yan, et al.
Psychological Medicine|May 28, 2026
Factors associated with social functioning by relapse frequency in Japanese outpatients with schizophrenia: the Multicenter Treatment Survey and Assessments for Schizophrenia in Psychiatric Clinics (MUSASI)Yoshiteru Takekita, Eiichi Katsumoto, Naoto Adachi, et al.
Cell Reports. Medicine|September 29, 2023
Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesiaYoshifumi Abe, Sho Yagishita, Hiromi Sano, et al.
BMC Psychiatry|November 19, 2013
Melancholic and reactive depression: a reappraisal of old categoriesJin Mizushima, Hitoshi Sakurai, Yuya Mizuno, et al.
Schizophrenia Research|June 2, 2023
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definitionGeorgios Schoretsanitis, A Elif Anıl Yağcıoğlu, Can-Jun Ruan, et al.
Schizophrenia Research|July 24, 2023
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studiesCan-Jun Ruan, Ismael Olmos, Carina Ricciardi, et al.
Pageof 17